Cargando…
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes
Fibroblast activation protein (FAP) is a proline-selective protease that belongs to the S9 family of serine proteases. It is typically highly expressed in the tumor microenvironment (TME) and especially in cancer-associated fibroblasts, the main cell components of the tumor stroma. The exact role of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114891/ https://www.ncbi.nlm.nih.gov/pubmed/33996747 http://dx.doi.org/10.3389/fchem.2021.640566 |
_version_ | 1783691139236233216 |
---|---|
author | Van Rymenant, Yentl Tanc, Muhammet Van Elzen, Roos Bracke, An De Wever, Olivier Augustyns, Koen Lambeir, Anne-Marie Kockx, Mark De Meester, Ingrid Van Der Veken, Pieter |
author_facet | Van Rymenant, Yentl Tanc, Muhammet Van Elzen, Roos Bracke, An De Wever, Olivier Augustyns, Koen Lambeir, Anne-Marie Kockx, Mark De Meester, Ingrid Van Der Veken, Pieter |
author_sort | Van Rymenant, Yentl |
collection | PubMed |
description | Fibroblast activation protein (FAP) is a proline-selective protease that belongs to the S9 family of serine proteases. It is typically highly expressed in the tumor microenvironment (TME) and especially in cancer-associated fibroblasts, the main cell components of the tumor stroma. The exact role of its enzymatic activity in the TME remains largely unknown. Hence, tools that enable selective, activity-based visualization of FAP within the TME can help to unravel FAP’s function. We describe the synthesis, biochemical characterization, and application of three different activity-based probes (biotin-, Cy3-, and Cy5-labeled) based on the FAP-inhibitor UAMC1110, an in-house developed molecule considered to be the most potent and selective FAP inhibitor available. We demonstrate that the three probes have subnanomolar FAP affinity and pronounced selectivity with respect to the related S9 family members. Furthermore, we report that the fluorescent Cy3- and Cy5-labeled probes are capable of selectively detecting FAP in a cellular context, making these chemical probes highly suitable for further biological studies. Moreover, proof of concept is provided for in situ FAP activity staining in patient-derived cryosections of urothelial tumors. |
format | Online Article Text |
id | pubmed-8114891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81148912021-05-13 In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes Van Rymenant, Yentl Tanc, Muhammet Van Elzen, Roos Bracke, An De Wever, Olivier Augustyns, Koen Lambeir, Anne-Marie Kockx, Mark De Meester, Ingrid Van Der Veken, Pieter Front Chem Chemistry Fibroblast activation protein (FAP) is a proline-selective protease that belongs to the S9 family of serine proteases. It is typically highly expressed in the tumor microenvironment (TME) and especially in cancer-associated fibroblasts, the main cell components of the tumor stroma. The exact role of its enzymatic activity in the TME remains largely unknown. Hence, tools that enable selective, activity-based visualization of FAP within the TME can help to unravel FAP’s function. We describe the synthesis, biochemical characterization, and application of three different activity-based probes (biotin-, Cy3-, and Cy5-labeled) based on the FAP-inhibitor UAMC1110, an in-house developed molecule considered to be the most potent and selective FAP inhibitor available. We demonstrate that the three probes have subnanomolar FAP affinity and pronounced selectivity with respect to the related S9 family members. Furthermore, we report that the fluorescent Cy3- and Cy5-labeled probes are capable of selectively detecting FAP in a cellular context, making these chemical probes highly suitable for further biological studies. Moreover, proof of concept is provided for in situ FAP activity staining in patient-derived cryosections of urothelial tumors. Frontiers Media S.A. 2021-04-14 /pmc/articles/PMC8114891/ /pubmed/33996747 http://dx.doi.org/10.3389/fchem.2021.640566 Text en Copyright © 2021 Van Rymenant, Tanc, Van Elzen, Bracke, De Wever, Augustyns, Lambeir, Kockx, De Meester and Van Der Veken. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry Van Rymenant, Yentl Tanc, Muhammet Van Elzen, Roos Bracke, An De Wever, Olivier Augustyns, Koen Lambeir, Anne-Marie Kockx, Mark De Meester, Ingrid Van Der Veken, Pieter In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title |
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title_full |
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title_fullStr |
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title_full_unstemmed |
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title_short |
In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes |
title_sort | in vitro and in situ activity-based labeling of fibroblast activation protein with uamc1110-derived probes |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114891/ https://www.ncbi.nlm.nih.gov/pubmed/33996747 http://dx.doi.org/10.3389/fchem.2021.640566 |
work_keys_str_mv | AT vanrymenantyentl invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT tancmuhammet invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT vanelzenroos invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT brackean invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT deweverolivier invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT augustynskoen invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT lambeirannemarie invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT kockxmark invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT demeesteringrid invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes AT vandervekenpieter invitroandinsituactivitybasedlabelingoffibroblastactivationproteinwithuamc1110derivedprobes |